THE HAGUE--Significant improvements in prostate cancer surgery in the Netherlands have reduced the number of men suffering from urinary incontinence following surgery by more than half, according to new figures showing major progress in patient recovery and surgical outcomes.
Until 2020, approximately 30 percent of men undergoing surgery to remove prostate cancer experienced urinary incontinence afterward. That figure dropped to an average of 14 percent between 2022 and 2024, according to health insurance data analysed by the Dutch Prostate Audit.
The improvement follows changes in surgical techniques, greater cooperation among urologists and the concentration of prostate cancer operations in a smaller number of specialised hospitals.
Incontinence means losing control over your bladder, causing urine to leak when you do not intend it to. For men who undergo prostate cancer surgery, this can happen because the operation may affect the muscles and nerves that help control urination.
Some men may experience small leaks when coughing, laughing, sneezing or lifting something heavy, while others may have difficulty holding their urine long enough to reach a toilet. The condition can be embarrassing and disruptive to daily life, sometimes requiring men to wear protective pads. In many cases, bladder control improves over time as the body heals, although some men may experience longer-lasting problems.
According to Dutch broadcaster NOS, one of the most important developments involved changes to how surgeons remove the prostate. Doctors discovered that preserving as much of the urethra as possible during surgery significantly improved patients' chances of maintaining urinary control.
The technique was identified as a successful practice at ZGT Hospital in Twente, where surgeons achieved substantially better results than many other hospitals. It has since become a standard approach across the Netherlands whenever medically possible.
The country's healthcare system also reduced the number of hospitals performing prostate cancer surgery from 19 to 14, allowing procedures to become more concentrated in specialised facilities.
Earlier research covering surgeries between 2016 and 2020 revealed major differences in outcomes among Dutch hospitals. At one hospital, 19 percent of patients experienced incontinence following surgery, compared with as many as 85 percent at another.
Those differences have narrowed considerably, with current hospital rates ranging between approximately 10 and 25 percent.
Rik Somford, a urologist at Canisius-Wilhelmina Hospital in Nijmegen who chairs the national improvement working group, explained to NOS that the earlier findings prompted specialists to cooperate more closely and reconsider established surgical practices.
Urologists now regularly evaluate treatment results across hospitals, focusing not only on urinary incontinence but also on cancer treatment effectiveness and the preservation of sexual function.
Despite the improvements, patients currently have limited access to information showing how individual hospitals perform. Patient organisations have called for greater transparency to help men make informed decisions about where to undergo treatment.
Beginning in 2027, Dutch hospitals are expected to publish selected surgical outcomes, including complications occurring within 90 days of surgery, whether the cancer was completely removed and the proportion of patients experiencing incontinence one year after their operations.
Medical specialists caution that comparisons between hospitals must account for differences in the complexity of patients' medical conditions, since hospitals treating more complicated cases may experience higher complication rates.
Prostate cancer remains the most frequently diagnosed cancer among men in the Netherlands. More than 16,000 men were diagnosed with the disease in 2025, while 3,334 deaths were recorded in 2024.
The latest findings highlight how improved surgical practices, specialised treatment and the systematic evaluation of patient outcomes can reduce complications associated with cancer treatment and improve men's quality of life following surgery.